Trial Profile
Effectiveness of lacosamide monotherapy in real-world clinical practice in patients with focal seizures
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 May 2017
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 06 May 2017 New trial record
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology